Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfonso Calvo

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
Cancers|July 2, 2021
Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence MalignanciesCora Palanca-Ballester, Aitor Rodriguez-Casanova, Susana Torres, et al.
Clinical Epigenetics|December 3, 2025
Genome-wide methylation analysis of circulating cell-free DNA identifies an episignature in lung cancer: validation of EMP2 as a potential biomarkerEster Alemany-Cosme, Dario Cruz-Chamorro, David Hervas, et al.
European Urology Oncology|September 4, 2019
Pazopanib as Second-line Antiangiogenic Treatment in Metastatic Renal Cell Carcinoma After Tyrosine Kinase Inhibitor (TKI) Failure: A Phase 2 Trial Exploring Immune-related Biomarkers for Testing in the Post-immunotherapy/TKI EraJoaquim Bellmunt, Emilio Esteban, Xabier García Del Muro, et al.
Cancer Letters|May 28, 2017
The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic nicheEduardo Castañón, Alex Soltermann, Inés López, et al.
International Journal of Radiation Oncology, Biology, Physics|March 14, 2026
A New Predictive Model for Radiation Necrosis Risk based on PTV-enriched Blood Inflammatory Biomarkers in Patients with Brain Metastases Treated with Stereotactic RadiosurgeryPaola Anna Jablonska, Diego Serrano, Nuria Galán, et al.
Journal of Clinical Medicine|December 11, 2019
TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC PatientsMaria Villalba, Francisco Exposito, Maria Jose Pajares, et al.
Translational Lung Cancer Research|December 10, 2025
Establishment and characterization of an orthotopic implanted lung cancer model to mimic human tumor structure, microenvironment, and metastatic spreadBeñat Picabea, Daniel Orive, Covadonga Rodríguez, et al.
Oncotarget|March 19, 2016
Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patientsMaria Villalba, Angel Diaz-Lagares, Miriam Redrado, et al.
International Journal of Cancer|January 30, 2014
New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterationsAnne-Marie Bleau, Javier Freire, María José Pajares, et al.
Histology and Histopathology|December 21, 2016
Development of biological tools to assess the role of TMPRSS4 and identification of novel tumor types with high expression of this prometastatic proteinMaria Villalba, Lissett Lopez, Miriam Redrado, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Cancers|July 2, 2021
Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence MalignanciesCora Palanca-Ballester, Aitor Rodriguez-Casanova, Susana Torres, et al.
Clinical Epigenetics|December 3, 2025
Genome-wide methylation analysis of circulating cell-free DNA identifies an episignature in lung cancer: validation of EMP2 as a potential biomarkerEster Alemany-Cosme, Dario Cruz-Chamorro, David Hervas, et al.
European Urology Oncology|September 4, 2019
Pazopanib as Second-line Antiangiogenic Treatment in Metastatic Renal Cell Carcinoma After Tyrosine Kinase Inhibitor (TKI) Failure: A Phase 2 Trial Exploring Immune-related Biomarkers for Testing in the Post-immunotherapy/TKI EraJoaquim Bellmunt, Emilio Esteban, Xabier García Del Muro, et al.
Cancer Letters|May 28, 2017
The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic nicheEduardo Castañón, Alex Soltermann, Inés López, et al.
International Journal of Radiation Oncology, Biology, Physics|March 14, 2026
A New Predictive Model for Radiation Necrosis Risk based on PTV-enriched Blood Inflammatory Biomarkers in Patients with Brain Metastases Treated with Stereotactic RadiosurgeryPaola Anna Jablonska, Diego Serrano, Nuria Galán, et al.
Journal of Clinical Medicine|December 11, 2019
TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC PatientsMaria Villalba, Francisco Exposito, Maria Jose Pajares, et al.
Translational Lung Cancer Research|December 10, 2025
Establishment and characterization of an orthotopic implanted lung cancer model to mimic human tumor structure, microenvironment, and metastatic spreadBeñat Picabea, Daniel Orive, Covadonga Rodríguez, et al.
Oncotarget|March 19, 2016
Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patientsMaria Villalba, Angel Diaz-Lagares, Miriam Redrado, et al.
International Journal of Cancer|January 30, 2014
New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterationsAnne-Marie Bleau, Javier Freire, María José Pajares, et al.
Histology and Histopathology|December 21, 2016
Development of biological tools to assess the role of TMPRSS4 and identification of novel tumor types with high expression of this prometastatic proteinMaria Villalba, Lissett Lopez, Miriam Redrado, et al.
Pageof 15